Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis. Aztreonam was effective in reducing the number of organisms in cerebrospinal fluid after single-dose and continuous infusio...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1985
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180117/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3890733/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.655 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|